Herceptin Biosimilar Market

Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein.
Herceptin Biosimilar Market contains market size and forecasts of Herceptin Biosimilar in global, including the following market information:
Global Herceptin Biosimilar Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Herceptin Biosimilar Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Herceptin Biosimilar companies in 2021 (%)
The global Herceptin Biosimilar market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Breast Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Herceptin Biosimilar include Amgen, AryoGen Biopharma, Biocon, Celltrion, Gedeon Richter, Genor Biopharma, Mabion, Mylan and Roche and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Herceptin Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Herceptin Biosimilar Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Herceptin Biosimilar Market Segment Percentages, by Type, 2021 (%)
Breast Cancer
Colorectal Cancer
Leukemia
Lymphoma
Other
Global Herceptin Biosimilar Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Herceptin Biosimilar Market Segment Percentages, by Application, 2021 (%)
Hospital & Clinics
Oncology Centers
Other
Global Herceptin Biosimilar Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Herceptin Biosimilar Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Herceptin Biosimilar revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Herceptin Biosimilar revenues share in global market, 2021 (%)
Key companies Herceptin Biosimilar sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Herceptin Biosimilar sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
AryoGen Biopharma
Biocon
Celltrion
Gedeon Richter
Genor Biopharma
Mabion
Mylan
Roche
The Instituto Vital Brazil